Literature DB >> 8198973

Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours.

B Ostenstad1, M Sioud, T Lea, E Schlichting, M Harboe.   

Abstract

The presence of T lymphocytes in solid tumours may reflect an ongoing immune response against the transformed cells. We have used polymerase chain reaction (PCR) technology to investigate the T-cell receptor variable-region gene (V-gene) usage in freshly isolated tumour-infiltrating lymphocytes (TILs) to look for a possible oligoclonality of T cells in the tumour area. We used 19 different V beta-family-specific primers. Peripheral blood lymphocytes and lamina propria lymphocytes from the same patients were also tested by PCR. Our results demonstrate a limited heterogeneity in the V-gene usage of TILs from seven patients with colorectal cancers, suggesting a local antigen-driven immune response at the tumour site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198973      PMCID: PMC1969442          DOI: 10.1038/bjc.1994.211

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.

Authors:  E R Fearon; D M Pardoll; T Itaya; P Golumbek; H I Levitsky; J W Simons; H Karasuyama; B Vogelstein; P Frost
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

3.  Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

Authors:  S A Rosenberg; B S Packard; P M Aebersold; D Solomon; S L Topalian; S T Toy; P Simon; M T Lotze; J C Yang; C A Seipp
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

4.  Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.

Authors:  A Belldegrun; A Kasid; M Uppenkamp; S L Topalian; S A Rosenberg
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

5.  Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.

Authors:  S L Topalian; L M Muul; D Solomon; S A Rosenberg
Journal:  J Immunol Methods       Date:  1987-08-24       Impact factor: 2.303

6.  Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.

Authors:  B Ostenstad; T Lea; E Schlichting; M Harboe
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

7.  Production of stable cytolytic T-cell clones directed against autologous human melanoma.

Authors:  M Hérin; C Lemoine; P Weynants; F Vessière; A Van Pel; A Knuth; R Devos; T Boon
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

8.  Stepwise immunologic selection of antigenic variants during tumor growth.

Authors:  J L Urban; M L Kripke; H Schreiber
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

9.  Lymphoid infiltration and prognosis in colorectal carcinoma.

Authors:  J L Svennevig; O C Lunde; J Holter; D Bjørgsvik
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

10.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  5 in total

1.  Proliferation of T-cell subsets that contact tumour cells in colorectal cancer.

Authors:  S J C Golby; C Chinyama; J Spencer
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.

Authors:  W J Bateman; I Donnellan; I A Fraser; L S Wong; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

3.  Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Authors:  S M Todryk; H Chong; R G Vile; H Pandha; N R Lemoine
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

4.  Evidence for monoclonal expansion of synovial T cells bearing V alpha 2.1/V beta 5.5 gene segments and recognizing a synthetic peptide that shares homology with a number of putative autoantigens.

Authors:  B Ostenstad; A Dybwad; T Lea; O Førre; O Vinje; M Sioud
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

5.  The immunogenicity of colorectal cancers with high-degree microsatellite instability.

Authors:  Ayan Banerjea; Stephen A Bustin; Sina Dorudi
Journal:  World J Surg Oncol       Date:  2005-05-12       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.